Syngene International, Asia’s leading Contract Research Organization, has completed a deal through which it has purchased assets of Strand Life Sciences related to systems biology, Heptox and pharma bioinformatics services. This includes target dossier business and rights to NGS data analytics and Sarchitect platforms, supported by a strong scientific team. This deal gives Syngene access to Strand’s patented Virtual Liver model and the NGS analytics platform.
Syngene International is one of Asia’s largest Contract Research Organizations, offers discovery and development services for novel molecular entities (NMEs) across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition.
| Company Name | CMP |
|---|---|
| Syngene Internation. | 436.55 |
| Indegene | 482.65 |
| CMS Info Systems | 317.60 |
| JITF Infralogistics | 331.25 |
| Sagility | 42.17 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: